SFN was found to inhibit the proliferation of AML stem-like cells in vitro and in vivo, by possibly decreasing the transcriptional and protein levels of components of the SHH pathway, one of the embryonic signaling pathways found to be dysregulated in CSCs. Here, SFN is linked to acute myeloid leukemia.